Literature DB >> 1331252

Aging and reactivation of latent murine cytomegalovirus.

K E Schmader1, R Rahija, K R Porter, G Daley, J D Hamilton.   

Abstract

BALB/c mice were experimentally infected with murine cytomegalovirus (MCMV) to discover whether latent MCMV persisted in aging mice and to examine the effect of aging on MCMV reactivation. Latently infected mice received saline, cyclophosphamide, or allogeneic blood at 6 and 18 months of age. MCMV DNA was detected by polymerase chain reaction in submaxillary salivary gland biopsy specimens from saline-treated young and old mice. Evidence of MCMV reactivation was sought by culture of biopsy specimens and by MCMV IgG ELISA of pre- and posttreatment sera from all animals. Very few cyclophosphamide- or saline-treated mice reactivated MCMV at either age, but young transfused mice reactivated MCMV significantly more often than did old transfused mice. These experiments indicate that MCMV DNA persists in the salivary gland of aging mice but that the likelihood of MCMV reactivation does not increase with age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331252     DOI: 10.1093/infdis/166.6.1403

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

Review 1.  Cytomegalovirus and the aging population.

Authors:  V C Emery
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency.

Authors:  M Hummel; Z Zhang; S Yan; I DePlaen; P Golia; T Varghese; G Thomas; M I Abecassis
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures.

Authors:  Yoshihiro Tsutsui; Hideya Kawasaki; Isao Kosugi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.

Authors:  C H Cook; A A Bickerstaff; J-J Wang; P D Zimmerman; M R Forster; T Nadasdy; R B Colvin; G A Hadley; C G Orosz
Journal:  Am J Transplant       Date:  2008-10-31       Impact factor: 8.086

5.  Potential Application of TALENs against Murine Cytomegalovirus Latent Infections.

Authors:  Shiu-Jau Chen; Yuan-Chuan Chen
Journal:  Viruses       Date:  2019-05-03       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.